Total Payments
$7,388
2024 Payments
$819.30
Companies
33
Transactions
338
Medicare Patients
1,384
Medicare Billing
$102,014
Payment Breakdown by Category
Food & Beverage$7,381 (99.9%)
Education$6.96 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,381 | 337 | 99.9% |
| Education | $6.96 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,422 | 66 | $0 (2024) |
| GENZYME CORPORATION | $1,368 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $725.76 | 38 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $512.03 | 18 | $0 (2024) |
| Lilly USA, LLC | $391.71 | 18 | $0 (2024) |
| UCB, Inc. | $347.96 | 15 | $0 (2024) |
| Celgene Corporation | $296.48 | 9 | $0 (2018) |
| PFIZER INC. | $295.64 | 19 | $0 (2024) |
| Galderma Laboratories, L.P. | $286.26 | 21 | $0 (2024) |
| Allergan, Inc. | $214.92 | 15 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $819.30 | 40 | GENZYME CORPORATION ($250.83) |
| 2023 | $967.63 | 42 | ABBVIE INC. ($214.17) |
| 2022 | $1,015 | 50 | GENZYME CORPORATION ($214.02) |
| 2021 | $1,070 | 52 | GENZYME CORPORATION ($337.95) |
| 2020 | $392.56 | 19 | GENZYME CORPORATION ($175.34) |
| 2019 | $1,122 | 45 | AbbVie, Inc. ($240.00) |
| 2018 | $1,153 | 55 | AbbVie, Inc. ($267.08) |
| 2017 | $849.15 | 35 | Celgene Corporation ($240.85) |
All Payment Transactions
338 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.17 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $124.34 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.42 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Immunology | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.52 | General |
| Category: Immunology | ||||||
| 09/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: Immunology | ||||||
| 09/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: Inflammation | ||||||
| 08/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.27 | General |
| Category: Immunology | ||||||
| 08/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: IMMUNOLOGY | ||||||
| 08/01/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: DERMATOLOGY | ||||||
| 07/31/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: DERMATOLOGY | ||||||
| 07/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.32 | General |
| Category: Immunology | ||||||
| 07/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: Immunology | ||||||
| 06/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: Immunology | ||||||
| 05/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: FACIAL AESTHETICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 372 | 588 | $88,478 | $27,019 |
| 2022 | 6 | 290 | 530 | $70,803 | $22,211 |
| 2021 | 8 | 336 | 531 | $93,189 | $26,147 |
| 2020 | 7 | 386 | 627 | $102,306 | $26,638 |
Total Patients
1,384
Total Services
2,276
Medicare Billing
$102,014
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 118 | $29,714 | $9,495 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 96 | $17,058 | $5,296 | 31.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 59 | 66 | $14,524 | $4,521 | 31.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 64 | 85 | $11,150 | $2,912 | 26.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $4,881 | $1,445 | 29.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 24 | 26 | $5,130 | $1,393 | 27.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,955 | $1,165 | 29.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 31 | 163 | $2,068 | $790.51 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 105 | $26,783 | $8,292 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 62 | 76 | $13,589 | $4,813 | 35.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 41 | 48 | $11,444 | $3,426 | 29.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 62 | 83 | $11,774 | $3,239 | 27.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 20 | 22 | $4,629 | $1,451 | 31.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 34 | 196 | $2,585 | $988.74 | 38.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 109 | $31,952 | $9,379 | 29.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 74 | $15,124 | $4,636 | 30.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 48 | 58 | $15,369 | $4,584 | 29.8% |
| 17000 | Destruction of skin growth | Office | 2021 | 65 | 83 | $13,329 | $2,872 | 21.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 21 | 24 | $5,858 | $1,676 | 28.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $5,772 | $1,394 | 24.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $3,534 | $891.65 | 25.2% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 37 | 156 | $2,251 | $714.47 | 31.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 135 | 173 | $46,628 | $12,233 | 26.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 66 | 77 | $21,115 | $5,932 | 28.1% |
| 17000 | Destruction of skin growth | Office | 2020 | 67 | 86 | $13,832 | $2,995 | 21.7% |
About Dr. Jeffrey Poole, M.D
Dr. Jeffrey Poole, M.D is a Dermatology healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518042134.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Poole, M.D has received a total of $7,388 in payments from pharmaceutical and medical device companies, with $819.30 received in 2024. These payments were reported across 338 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($7,381).
As a Medicare-enrolled provider, Poole has provided services to 1,384 Medicare beneficiaries, totaling 2,276 services with total Medicare billing of $102,014. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Pediatric Dermatology
- Location Metairie, LA
- Active Since 10/25/2006
- Last Updated 09/11/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1518042134
Products in Payments
- DUPIXENT (Biological) $1,538
- COSENTYX (Biological) $660.19
- Humira (Biological) $528.60
- TALTZ (Drug) $373.99
- RINVOQ (Biological) $355.01
- Cimzia (Drug) $295.65
- Otezla (Drug) $282.45
- EUCRISA (Drug) $241.52
- SKYRIZI (Biological) $227.83
- ADBRY (Biological) $146.49
- DUPIXENT (Drug) $136.34
- STELARA (Biological) $125.00
- DUOBRII (Drug) $107.55
- HUMIRA (Biological) $106.99
- Sotyktu (Drug) $95.53
- SILIQ (Drug) $84.69
- DORYX (Drug) $80.78
- TREMFYA (Drug) $66.60
- VYJUVEK (Drug) $64.18
- OPZELURA (Drug) $61.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Metairie
Dr. Katherine Holcomb, M.d, M.D
Dermatology — Payments: $528,956
Dermatology $528,956
Dr. Robert Koppel, M.d, M.D
Dermatology — Payments: $244,579
Dermatology $244,579
Dr. Keith Leblanc, M.d, M.D
Dermatology — Payments: $74,520
Dermatology $74,520
Dr. William Coleman, M.d, M.D
Dermatology — Payments: $72,159
Dermatology $72,159
Dr. Rachael Delahoussaye-Shields, M.d, M.D
Dermatology — Payments: $66,359
Dermatology $66,359
Michelle Gerdes, Md, MD
Dermatology — Payments: $28,001
Dermatology $28,001